Keywords
Abstract
Clinical incident reporting is a critical component of healthcare systems worldwide, serving as a mechanism to identify, analyze, and mitigate adverse events to enhance patient safety. In Uzbekistan, the landscape of clinical incident reporting is evolving, influenced by healthcare reforms and the integration of pharmacovigilance practices. This article examines the current state of clinical incident reporting in Uzbekistan, highlighting existing challenges, recent advancements, and future prospects. Through an analysis of available literature and regulatory frameworks, the discussion emphasizes the importance of a robust incident reporting system in fostering a culture of safety and continuous improvement in healthcare delivery.
References
Ministry of Health of the Republic of Uzbekistan. (2023). Regulations on Pharmacovigilance and Clinical Incident Reporting.
2. World Health Organization (WHO). (2022). Global Patient Safety Action Plan 2021-2030.
3. Uppsala Monitoring Centre (UMC). (2023). Uzbekistan and the WHO Programme for International Drug Monitoring.
4. Cratia. (2023). Pharmacovigilance in Uzbekistan.
5. Pharmex. (2023). Advancing Drug Safety Monitoring in Uzbekistan.
6. Biomed Central (BMC). (2021). Barriers to Clinical Incident Reporting in Developing Healthcare Systems. BMC Health Services Research, 21, 7350.
7. Fayllar. (2023). Clinical Incident Reporting in Uzbekistan